MX2015010315A - Fabricacion de formulaciones de mani para desensibilizacion oral. - Google Patents

Fabricacion de formulaciones de mani para desensibilizacion oral.

Info

Publication number
MX2015010315A
MX2015010315A MX2015010315A MX2015010315A MX2015010315A MX 2015010315 A MX2015010315 A MX 2015010315A MX 2015010315 A MX2015010315 A MX 2015010315A MX 2015010315 A MX2015010315 A MX 2015010315A MX 2015010315 A MX2015010315 A MX 2015010315A
Authority
MX
Mexico
Prior art keywords
peanut
manufacture
oral desensitization
formulations
oral
Prior art date
Application number
MX2015010315A
Other languages
English (en)
Inventor
Bryan Walser
Howard V Raff
Original Assignee
Aimmune Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51528061&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2015010315(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aimmune Therapeutics Inc filed Critical Aimmune Therapeutics Inc
Publication of MX2015010315A publication Critical patent/MX2015010315A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal

Abstract

La presente solicitud se relaciona a un método para el manejo del proceso de fabricación y desarrollo de una formulación terapéuticamente efectiva. Las proteínas de maní se caracterizan de harina de maní y formulaciones encapsuladas hechas utilizando la harina de maní para la inmunoterapia oral de alergias al maní.
MX2015010315A 2013-03-14 2014-03-12 Fabricacion de formulaciones de mani para desensibilizacion oral. MX2015010315A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361784964P 2013-03-14 2013-03-14
PCT/US2014/024401 WO2014159607A1 (en) 2013-03-14 2014-03-12 Manufacture of peanut formulations for oral desensitization

Publications (1)

Publication Number Publication Date
MX2015010315A true MX2015010315A (es) 2016-04-13

Family

ID=51528061

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015010315A MX2015010315A (es) 2013-03-14 2014-03-12 Fabricacion de formulaciones de mani para desensibilizacion oral.

Country Status (18)

Country Link
US (5) US9198869B2 (es)
EP (3) EP3998080A1 (es)
JP (3) JP6752140B2 (es)
CN (2) CN105101994B (es)
AU (5) AU2014240404B2 (es)
BR (1) BR112015021756B1 (es)
CA (1) CA2903229A1 (es)
DK (2) DK3482771T3 (es)
ES (2) ES2826224T3 (es)
FI (2) FI3482771T3 (es)
FR (1) FR23C1026I1 (es)
HK (1) HK1217660A1 (es)
HU (1) HUE051831T2 (es)
MX (1) MX2015010315A (es)
PL (1) PL2968529T3 (es)
PT (1) PT2968529T (es)
SI (1) SI2968529T1 (es)
WO (1) WO2014159607A1 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2924349B1 (fr) 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
US9492535B2 (en) 2013-03-14 2016-11-15 Aimmune Therapeutics, Inc. Peanut formulations and uses thereof
JP6752140B2 (ja) 2013-03-14 2020-09-09 アイミューン セラピューティクス，インコーポレイテッド 経口脱感作のための落花生処方物の製造
CA2955252A1 (en) 2014-08-25 2016-03-03 Aimmune Therapeutics, Inc. Egg protein formulations and methods of manufacture thereof
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
PL3258962T3 (pl) 2015-02-20 2023-04-24 The Board Of Trustees Of The Leland Stanford Junior University Mieszane kompozycje alergenów i sposoby ich stosowania
US10166286B2 (en) 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10149904B2 (en) 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10143742B2 (en) 2015-02-20 2018-12-04 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US11452774B2 (en) 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
TW201709926A (zh) * 2015-04-23 2017-03-16 賽諾菲公司 用於舌下投藥之吡喃葡萄糖基脂ａ及過敏原調配物
US10856567B2 (en) 2016-07-22 2020-12-08 Kari Brown Baby food products containing allergenic proteins and methods of delivering same
AU2016431600A1 (en) * 2016-12-05 2019-04-04 Reacta Biotech Limited Oral food challenge meal formulations
CN110381749A (zh) * 2017-01-13 2019-10-25 艾慕恩治疗公司 坚果粉的制造方法和用于口服免疫疗法的配方
BR102017026619A2 (pt) 2017-02-15 2018-10-30 Euroimmun Medizinische Labordiagnostika Ag ensaio melhorado para a diagnose de alergia a amendoim
NZ760884A (en) 2017-07-18 2023-05-26 Nestle Sa Methods for making mixed allergen compositions
US11369676B2 (en) 2017-11-02 2022-06-28 Société des Produits Nestlé S.A. Methods of oral immunotherapy
GB201718342D0 (en) * 2017-11-06 2017-12-20 Cambridge Allergy Ltd Allergenic protein formulations for immunotherapy
JP7319351B2 (ja) 2018-07-27 2023-08-01 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 経口免疫療法の単位用量分配システムおよび方法
WO2020131917A1 (en) * 2018-12-17 2020-06-25 Aimmune Therapeutics, Inc. Formulations for egg oral immunotherapy, methods of manufacture, and treatments for egg allergy
US20200230206A1 (en) * 2018-12-20 2020-07-23 Aimmune Therapeutics, Inc. Peanut oral immunotherapy dosing schedule for missed doses
AU2020213085A1 (en) 2019-01-23 2021-08-12 Société des Produits Nestlé S.A. Methods for making mixed allergen compositions
WO2020231843A1 (en) 2019-05-10 2020-11-19 Aimmune Therapeutics, Inc. Methods for improving the quality of life of a patient with a peanut allergy
KR20220044543A (ko) * 2019-08-08 2022-04-08 에보니크 오퍼레이션즈 게엠베하 고체 투여 형태를 제조하는 방법 및 윤활제
WO2021127722A1 (en) * 2019-12-23 2021-07-01 Prota Therapeutics Pty Ltd Pharmaceutical compositions
US20220220211A1 (en) 2021-01-08 2022-07-14 Regeneron Pharmaceuticals, Inc. Methods for treating peanut allergy and enhancing peanut allergen-specific immunotherapy by administering an il-4r antagonist
WO2023198674A1 (en) 2022-04-11 2023-10-19 Alk-Abelló A/S Peanut allergen composition

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3809767A (en) * 1969-05-12 1974-05-07 Griffith Laboratories Methods of making vegetable protein concentrates
AU1589492A (en) 1991-03-01 1992-10-06 Warner-Lambert Company Starch-based controlled release compositions
US20120164306A1 (en) * 1993-08-03 2012-06-28 Girsh Leonard S Process for preparing hypoallergenic and reduced fat foods
JP3445593B2 (ja) * 1994-09-10 2003-09-08 株式会社林原生物化学研究所 ペプチドとその用途
AU1951201A (en) 1999-12-06 2001-06-12 Mount Sinai School Of Medicine Of The City University Of New York, The Peptide antigens
AU1951001A (en) * 2000-04-06 2001-09-17 Panacea Pharm Llc Microbial delivery system
CA2516291C (en) * 2003-02-28 2012-02-14 Alk-Abello A/S Dosage form having a saccharide matrix
EP1734975B1 (en) * 2004-03-19 2015-06-10 Herbs Spring, LLC Herbal therapy for the treatment of food allergy
JP2009522258A (ja) * 2005-12-28 2009-06-11 テバ ファーマシューティカル インダストリーズ リミティド 増大したバイオアベイラビリティを有するフェノフィブラートの医薬製剤
FR2924349B1 (fr) * 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
WO2010059534A2 (en) 2008-11-19 2010-05-27 Mallinckrodt Baker, Inc. Directly compressible granular microcrystalline cellulose based excipient, manufacturing process and use thereof
US8399519B2 (en) 2008-12-19 2013-03-19 Merz Pharma Gmbh & Co. Kgaa 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
US8329208B2 (en) * 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
EP2364690A1 (en) 2010-02-12 2011-09-14 Centro De Ingenieria Genetica Y Biotecnologia Orally administrable pharmaceutical pellet of epidermal growth factor
JP5800527B2 (ja) * 2010-03-30 2015-10-28 日東電工株式会社 安定化医薬組成物、安定化医薬組成物溶液製剤、フィルム状製剤及びフィルム状製剤の製造方法
UY33472A (es) * 2010-06-30 2012-01-31 Novartis Ag ?composiciones farmacéuticas que comprenden monohidrato de lactato de 4-amino-5-fluoro-3-[6-(4-metil-piperazin-1-il)-1hbencimidazol-2-il]-1h-quinolin-2-ona?.
CN101912364B (zh) * 2010-08-09 2015-07-15 刘会梅 银杏内酯b脂质体组合药物
GB201104537D0 (en) 2011-03-17 2011-05-04 Cambridge Entpr Ltd Treatment for peanut allergy
EP2750705B1 (en) * 2011-08-31 2022-11-16 Perosphere Technologies Inc. Methods for effectively and rapidly desensitizing allergic patients
WO2013087119A1 (en) * 2011-12-16 2013-06-20 Hal Allergy Holding B.V. Pharmaceutical formulations and the use thereof for the treatment of peanut allergy
US9492535B2 (en) * 2013-03-14 2016-11-15 Aimmune Therapeutics, Inc. Peanut formulations and uses thereof
JP6752140B2 (ja) * 2013-03-14 2020-09-09 アイミューン セラピューティクス，インコーポレイテッド 経口脱感作のための落花生処方物の製造
CA2955252A1 (en) 2014-08-25 2016-03-03 Aimmune Therapeutics, Inc. Egg protein formulations and methods of manufacture thereof
CN110381749A (zh) 2017-01-13 2019-10-25 艾慕恩治疗公司 坚果粉的制造方法和用于口服免疫疗法的配方
US11369676B2 (en) 2017-11-02 2022-06-28 Société des Produits Nestlé S.A. Methods of oral immunotherapy

Also Published As

Publication number Publication date
AU2018222980A1 (en) 2018-09-20
EP2968529B1 (en) 2020-08-05
EP2968529A1 (en) 2016-01-20
HK1217660A1 (zh) 2017-01-20
CN105101994A (zh) 2015-11-25
FR23C1026I1 (fr) 2023-10-06
PT2968529T (pt) 2020-11-10
AU2020202685A1 (en) 2020-05-14
US9198869B2 (en) 2015-12-01
BR112015021756B1 (pt) 2023-01-10
JP6891205B2 (ja) 2021-06-18
US20160030289A1 (en) 2016-02-04
DK3482771T3 (da) 2023-03-20
US10449118B2 (en) 2019-10-22
AU2020202685B2 (en) 2022-01-20
ES2940686T3 (es) 2023-05-10
US20200129378A1 (en) 2020-04-30
ES2826224T3 (es) 2021-05-17
BR112015021756A8 (pt) 2019-11-19
JP6752140B2 (ja) 2020-09-09
CN105101994B (zh) 2018-10-12
AU2022201858A1 (en) 2022-04-07
US20180042816A1 (en) 2018-02-15
FIC20230022I1 (fi) 2023-07-04
JP2016512537A (ja) 2016-04-28
DK2968529T3 (da) 2020-10-12
EP3482771A1 (en) 2019-05-15
AU2014240404A1 (en) 2015-09-17
PL2968529T3 (pl) 2021-04-19
JP7454519B2 (ja) 2024-03-22
US11141352B2 (en) 2021-10-12
WO2014159607A1 (en) 2014-10-02
CN109125283A (zh) 2019-01-04
AU2022201858B2 (en) 2024-04-04
BR112015021756A2 (pt) 2017-07-18
US20140271836A1 (en) 2014-09-18
JP2019108357A (ja) 2019-07-04
AU2014240404B2 (en) 2016-07-21
FI3482771T3 (fi) 2023-04-03
AU2016231523B2 (en) 2018-05-31
EP2968529A4 (en) 2016-10-05
US20230120350A1 (en) 2023-04-20
EP3482771B1 (en) 2023-01-18
EP3998080A1 (en) 2022-05-18
HUE051831T2 (hu) 2021-03-29
CA2903229A1 (en) 2014-10-02
JP2021073321A (ja) 2021-05-13
AU2016231523A1 (en) 2016-10-06
SI2968529T1 (sl) 2021-03-31

Similar Documents

Publication Publication Date Title
MX2015010315A (es) Fabricacion de formulaciones de mani para desensibilizacion oral.
PH12015501435A1 (en) Oral care products comprising a tetrabasic zinc - amino acid - halide complex
PH12015502293A1 (en) Bispecific antibodies specific for fap and dr5, antibodies specific for dr5 and methods of use
EP3053185A4 (en) Internal spacers for nanowire transistors and method of fabrication thereof
MX2019008419A (es) Métodos de fabricación de harinas de nueces y formulaciones para inmunoterapia oral.
EP3014496A4 (en) Additive manufacturing system and method of manufacture
EP3074360A4 (en) Process and apparatus for manufacture of portland cement
EP2991108A4 (en) Semiconductor device and method of manufacture thereof
EP3083939A4 (en) Compositions for cellular restoration and methods of making and using same
EP3048928A4 (en) Capsule cosmetics and manufacturing method thereof
EP3003207A4 (en) Dental appliance system and method of manufacture
IL243667A0 (en) A crush-resistant material that combines fly ash and a production method
EP3018699A4 (en) Impurity-diffusing composition and method for producing semiconductor element
EP2969490A4 (en) MOLDABLE CAPSULE AND METHOD OF MANUFACTURE
EP3025720A4 (en) Preparation method for therapeutic agent of bead-type chondrocyte
EP3078109A4 (en) Power suppy and method of manufacturing
PL2967110T3 (pl) Przekąski w postaci gumy do żucia oraz sposoby ich wytwarzania
EP3160299A4 (en) Oral care implement and method of manufacturing an oral care implement
EP2994483A4 (en) Methods and compositions related to large scale production of proteins
EP3057992A4 (en) Human antibody against aggrecanase-type adamts species for therapeutics of aggrecanase-related diseases
EP3019446A4 (en) New form of silicon and method of making the same
ZA201507881B (en) Coated chewing gum and its process of manufacture
EP3046937A4 (en) Modified anti-inflammatory proteins and method of use
AR091136A1 (es) Metodo de cementado y composicion fraguable
EP3039712A4 (en) Semiconductor device and method of making same